| Synonyms: | |
| Status: | Approved (1968) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | V03AC01 |
| UNII: | J06Y7MXW4D |
| InChI Key | UBQYURCVBFRUQT-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H48N6O8 |
| Molecular Weight | 560.69 |
| AlogP | 0.92 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 6.0 |
| Number of Rotational Bond | 23.0 |
| Polar Surface Area | 205.84 |
| Molecular species | BASE |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 39.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 5000 | - | - | - | |
|
Secreted protein
|
- | - | - | - | 87-94 | |
|
Transcription factor
|
17800 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| beta-Thalassemia | 3 | D017086 | ClinicalTrials |
| Hemochromatosis | 3 | D006432 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Cerebral Hemorrhage | 2 | D002543 | ClinicalTrials |
| Anemia, Sickle Cell | 2 | D000755 | ClinicalTrials |
| Acute Kidney Injury | 2 | D058186 | ClinicalTrials |
| Ischemic Stroke | 2 | D000083242 | ClinicalTrials |
| Subarachnoid Hemorrhage | 2 | D013345 | ClinicalTrials |
| Diabetic Foot | 2 | D017719 | ClinicalTrials |
| Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
| Thalassemia | 1 | D013789 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 70-51-9 |
| ChEBI | 4356 |
| ChEMBL | CHEMBL556 |
| DrugBank | DB00746 |
| DrugCentral | 792 |
| EPA CompTox | DTXSID7022887 |
| FDA SRS | J06Y7MXW4D |
| Human Metabolome Database | HMDB0014884 |
| PharmGKB | PA164746490 |
| PubChem | 2973 |
| SureChEMBL | SCHEMBL34571 |
| ZINC | ZINC000003830635 |